1. Home
  2. > Healthcare Market Trends
Global Postpartum Hemorrhage Devices Market Size, Share & Industry Trends Analysis Report By Product, By Regional Outlook and Forecast, 2022 – 2028

Global Postpartum Hemorrhage Devices Market Size, Share & Industry Trends Analysis Report By Product, By Regional Outlook and Forecast, 2022 – 2028

  • May 2022
  • 118 pages
  • ID: 6289281
  • Format: PDF
  • KBV Research


Table of Contents

The Global Postpartum Hemorrhage (PPH) Devices Market size is expected to reach $1.05 billion by 2028, rising at a market growth of 5.2% CAGR during the forecast period.

Postpartum hemorrhage (PPH) is the most prevalent type of obstetric hemorrhage and one of the primary causes of maternal mortality. Blood loss from vaginal or cesarean delivery is known as PPH. Postpartum hemorrhage is classified based on the amount of blood lost. Blood loss of less than 500 mL is considered primary PPH, while blood loss of more than 500 mL is considered secondary PPH. Modern PPH treatment devices outperform previous procedures since they are designed to treat uterine diseases and difficulties with uterine contractions. PPH devices are non-pneumatic anti-shock garments, uterine balloon tamponade, and inject prefilled injectable systems that are used as second-line intervention devices. These devices are helpful in stopping blood flow and stabilizing the patient’s condition until more serious medical help arrives.

Uterine atony, a disease in which the uterus fails to contract following the birth of the baby, is the most prevalent cause of PPH. First response interventions, such as uterotonic drugs (primarily oxytocin), isotonic crystalloids, tranexamic acid, and uterine massage; and, if necessary, refractory PPH interventions, such as compressive measures (aortic compression or bimanual uterine compression), intrauterine balloon tamponade, and nonpneumatic anti shock garment (NASG). Surgical intervention (compressive sutures, artery ligation, or hysterectomy) is required if these methods fail. In 2012, the World Health Organization (WHO) issued a conditional recommendation in favor of uterine balloon tamponade (UBT) in cases when uterotonics were unavailable or ineffective in reducing bleeding.

COVID-19 Impact

The COVID-19 pandemic wrought havoc on people’s health and the economy around the world. It has had an impact on entire economies and businesses, as well as individual careers and lives. The outbreak also led to the unfortunate demise of millions across the world. As enterprises turn their focus away from development prospects and onto implementing exceptional measures to avoid the harmful impact of the COVID-19 pandemic, the stress of maintaining revenue levels at pre-COVID levels has become the new normal.

The postpartum hemorrhage devices market is expected to rise in response to the COVID-19 outbreak. Covid-19 infection raises the risk of pregnancy complications such as postpartum hemorrhage, which helps the market grow by increasing the number of PPH patients.

Market Growth Factors

Rise in Complications Like Obstetric Hemorrhage

The postpartum hemorrhage devices market is growing due to a rise in complications such as acute postpartum hemorrhage. The most common and dangerous complication of childbirth is obstetric hemorrhage. Postpartum hemorrhage (PPH) is traditionally described as a blood loss of more than 500 mL estimated with a vaginal delivery or more than 1000 mL estimated during a cesarean delivery. The American College of Obstetrics and Gynecology characterized this in 2017 as an accumulation of blood loss of more than 1000 mL with signs and symptoms of hypovolemia within 24 hours after the birth procedure, regardless of delivery mode.

Growing Investment in Healthcare Sector in Developed and Developing Countries

Governments of developing countries such as India and China are investing heavily in the healthcare sector of their respective countries. In 2020, for instance, the Indian health tech business was estimated to be worth $1.9 billion. It is predicted to reach $ 5 billion by 2023, with a CGAR of 39%. The Indian digital healthcare market was worth USD 1.50 billion in 2018 and is expected to grow to USD 6.26 billion by 2024. The expansion of the healthcare business is likely to positively impact the postpartum hemorrhage devices market. Even in developed countries, such as the United States, governments are spending enormous amounts to modernize and expand the healthcare sector.

Market Restraining Factors

Inaccuracies in Measuring Blood Loss in Obstetric Hemorrhage

Postpartum hemorrhage is the leading cause of maternal death in the United States, accounting for about 11% of all maternal deaths. Significantly, obstetric hemorrhage is responsible for 54-93% of maternal deaths. Health care providers’ inaccurate estimation of actual blood loss at the time of birth and in the immediate postpartum period is a major cause of delayed hemorrhage response, according to studies. Underestimations of blood loss lead healthcare providers into believing that deployment of postpartum hemorrhage are not necessary, thus, limiting the use of postpartum hemorrhage devices.

Product Outlook

Based on Product, the market is segmented into Uterine Tamponade Devices, Prefilled Injection System, and Non-Pneumatic Anti-Shock Garment. The uterine tamponade devices segment acquired the largest revenue share in the postpartum hemorrhage devices market in 2021. This is due to the device’s ability to work quickly and reduce the need for risky and expensive surgical procedures. Furthermore, the device is quick responding and less intrusive, making it a safe way to manage PPH. Moreover, since the gadget kit contains few pieces, it can be installed quickly and easily, increasing its efficacy.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The Asia Pacific acquired the highest revenue share in the postpartum hemorrhage devices market in 2021. Government initiatives to reduce maternal deaths and enable access to preferred therapy for effective management throughout the third phase of labor are projected to benefit the Asia-Pacific market even more and raise the demand for PPH devices in the upcoming years. Furthermore, the region’s dearth of skilled caretakers, operating skills, and blood-transfusion facilities are expected to fuel the demand for PPH treatment devices.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Becton, Dickinson and Company, Bactiguard Holding AB, Utah Medical Products, Inc., Organon & Co., Cook Medical, Inc., PATH, Obstetrx, Inc., Zoex Corporation, and 3rd Stone Design, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

• Uterine Tamponade Devices

• Prefilled Injection System

• Non-Pneumatic Anti-Shock Garment

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific


o Brazil

o Argentina


o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Teleflex, Inc.

• Becton, Dickinson and Company

• Bactiguard Holding AB

• Utah Medical Products, Inc.

• Organon & Co.

• Cook Medical, Inc.


• Obstetrx, Inc.

• Zoex Corporation

• 3rd Stone Design, Inc.

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Gastrointestinal Devices Global Market Report 2023

  • $ 5000
  • February 2023
  • 250 pages

Major players in the gastrointestinal devices market are Boston Scientific, Medtronic, Fujifilm Holdings Corporation, CONMED Corporation, Stryker Corporation, Johnson and Johnson, Olympus, Cook Group, ...

  • World
  • United States
  • Healthcare
  • Digestive System Disorder
  • Industry analysis
  • Health Expenditure
  • Mental Health Expenditure


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on